These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7843363)

  • 1. Influenza vaccines: a main problem in control of pandemics.
    Ghendon Y
    Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technologies for influenza vaccines.
    Dormitzer PR; Tsai TF; Del Giudice G
    Hum Vaccin Immunother; 2012 Jan; 8(1):45-58. PubMed ID: 22251994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging cell culture manufacturing technologies for influenza vaccines.
    Milián E; Kamen AA
    Biomed Res Int; 2015; 2015():504831. PubMed ID: 25815321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses.
    Jin H; Chen Z
    Curr Opin Virol; 2014 Jun; 6():34-9. PubMed ID: 24705137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for pandemic influenza.
    Luke CJ; Subbarao K
    Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines in development against avian influenza.
    Cox MM
    Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of influenza vaccine strains and developing pandemic vaccines.
    Wood JM
    Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pandemic influenza vaccine in India: from strain to sale within 12 months.
    Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
    Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
    Kreijtz JH; Osterhaus AD; Rimmelzwaan GF
    Hum Vaccin; 2009 Mar; 5(3):126-35. PubMed ID: 18948744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccines: from whole virus preparations to recombinant protein technology.
    Huber VC
    Expert Rev Vaccines; 2014 Jan; 13(1):31-42. PubMed ID: 24192014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus.
    Carter NJ; Plosker GL
    BioDrugs; 2008; 22(5):279-92. PubMed ID: 18778110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.